(S)-(4-chloro-2-fluorophenyl)(3-(4-(4-ethylpiperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-ylamino)pyrrolidin-1-yl)methanone

ID: ALA5078321

Chembl Id: CHEMBL5078321

PubChem CID: 164120834

Max Phase: Preclinical

Molecular Formula: C25H31ClFN9O

Molecular Weight: 528.04

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2cc(Nc3cc(C)[nH]n3)nc(N[C@H]3CCN(C(=O)c4ccc(Cl)cc4F)C3)n2)CC1

Standard InChI:  InChI=1S/C25H31ClFN9O/c1-3-34-8-10-35(11-9-34)23-14-21(29-22-12-16(2)32-33-22)30-25(31-23)28-18-6-7-36(15-18)24(37)19-5-4-17(26)13-20(19)27/h4-5,12-14,18H,3,6-11,15H2,1-2H3,(H3,28,29,30,31,32,33)/t18-/m0/s1

Standard InChI Key:  YFIGOXZDFNSYNP-SFHVURJKSA-N

Alternative Forms

  1. Parent:

    ALA5078321

    ---

Associated Targets(Human)

AURKA Tchem Serine/threonine-protein kinase Aurora-A (10240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H82 (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H211 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H446 (443 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H524 (124 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2171 (837 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H526 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H209 (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H146 (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-BE(2) (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 528.04Molecular Weight (Monoisotopic): 527.2324AlogP: 3.51#Rotatable Bonds: 7
Polar Surface Area: 105.31Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.25CX Basic pKa: 7.63CX LogP: 4.03CX LogD: 3.60
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.43Np Likeness Score: -2.28

References

1. Chi YH, Yeh TK, Ke YY, Lin WH, Tsai CH, Wang WP, Chen YT, Su YC, Wang PC, Chen YF, Wu ZW, Yeh JY, Hung MC, Wu MH, Wang JY, Chen CP, Song JS, Shih C, Chen CT, Chang CP..  (2021)  Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.,  64  (11.0): [PMID:34009981] [10.1021/acs.jmedchem.0c01806]

Source